Chantal Mathieu

KU Leuven

Papers (1)

• 2024Primary author
  A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab.10.1007/s00125-023-06014-2